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occurs in 2 forms after cardiac operation: a clinically
obvious deficit occurs in 3% of patients and is attributed
to embolization of atherosclerotic debris during manip-
ulation of the diseased aorta; cognitive impairment
occurs in two thirds of patients early after operation
and, more importantly, is reported to persist in one third
of patients for at least 1 year after operation. The pre-
cise pathophysiologic features of cognitive impairment
are not certain but have been attributed to the microem-
bolic, inflammatory, and nonphysiologic perfusion fac-
tors associated with cardiopulmonary bypass (CPB).2
Cognitive impairment also occurs after noncardiac
operations but is reported to be more frequent and
severe after cardiac operation with CPB.3-9 Although
cognitive impairment after noncardiac operation is
A dvances in the protection of the heart and otherorgans during cardiac operation leaves acute cere-
bral injury as the major limitation.1 Cerebral injury
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explained by patient-related factors (eg, advanced age,
ill health), impairment that occurs after cardiac opera-
tion is invariably attributed to CPB.3-9
The feasibility of the performance of certain coronary
grafts without CPB has recently been established.
Grafts to the left anterior descending and right coronary
artery can be performed with minimal disturbance of the
heart and the avoidance of CPB; grafts to the circumflex
artery require significant manipulation of the heart and
CPB to support the circulation. It has been postulated,
but not proved, that avoidance of CPB may reduce the
postoperative morbidity associated with extracorporeal
circulation. Specifically, it is suggested that coronary
artery bypass grafting (CABG) without CPB should
minimize postoperative cognitive impairment. Testing
this hypothesis ideally requires a randomized trial of
patients undergoing CABG with and without CPB. 
To investigate the current impact of CPB on cognitive
functioning, we compared neuropsychologic perfor-
mance at discharge and at 3 months in patients under-
going CABG with and without CPB. Furthermore,
functional performance as measured by the comprehen-
sive multidimensional measure of subjective health sta-
tus (SF36) was compared before and 3 months after the
operation. The SF36 is a generic measure of subjective
health status that assesses daily function covering phys-
ical and social function, emotional problems, bodily
pain, vitality, and health perceptions.10 We hypothesized
that if CPB is the cause of neuropsychologic impair-
ment over and above other intraoperative factors then
patients undergoing CABG without CPB would be
expected to show better psychometric performance than
those patients undergoing CABG with CPB. 
Methods
Patients. The 50 patients with CPB in the current study
were from a group of 150 patients undergoing CPB and were
taking part in a trial, “A Phase 2 Study Assessing the Effect
of a 12 Hour Infusion of Lexipifant on Myocardial Damage,
Lung Injury, and Cerebral Dysfunction in Patients Under-
going Coronary Artery Bypass Grafting” between February
1996 and March 1997. This trial was approved by the Central
Oxford Research Ethics Committee (“95.280”). All patients
gave written informed consent to participate in this trial. The
patients undergoing nonbypass studies gave consent to follow
the same protocol as the patients in the cardiopulmonary trial.
This study did not require ethical committee approval
because it did not involve randomization of patients and did
not involve invasive measurements. The inclusion criteria for
that study included patients undergoing first-time CABG for
angiographically demonstrated coronary stenoses. Exclusion
criteria included emergency operation, significantly impaired
ventricular function (ejection fraction < 30%), or a previous
cerebrovascular accident. 
The 25 patients undergoing CABG without CPB were from
a group of 26 such patients who underwent operation con-
secutively between March 1996 and February 1997. One
patient who underwent an emergency operation was not
included in neuropsychologic testing. The patients without
CPB were defined solely by the absence of circumflex coro-
nary artery disease on preoperative coronary angiography and
otherwise met all criteria to be entered into the anti-inflam-
matory trial. Each patient without CPB was matched with 2
patients with CPB in terms of age and sex. As a consequence
of this a priori matching, the groups were also found to be
closely matched for pre-existing hypertension and ventricular
function. These factors (except sex) may influence, albeit
weakly, postoperative neuropsychologic outcome.2,9
Anesthesia. The patients with CPB and without CPB
received the same anesthetic regimen. Premedication was
achieved with morphine (10-15 mg) and scopolamine (0.3-
0.4 mg). Anesthesia was induced with fentanyl (1 mg), pan-
curonium (8 mg), and etomidate (4-10 mg). Anesthesia was
maintained with a combination of oxygen, nitrous oxide, and
halothane before CPB and during CPB with propofol (6
mg/kg per hour). Benzodiazepines were not used.
Operation. One surgeon (D.P.T.) performed all operations
through a median sternotomy incision. CABG without CPB
was performed in patients whose condition required grafts to
any coronary vessels, excluding the circumflex marginal or
its branches. These patients received half-dose heparin, and
the heart was displaced medially with a swab placed in the
left side of the pericardium. This usually reduced the mean
arterial pressure to 50 to 60 mm Hg, but if necessary a short-
acting b -blocker was added to reduce blood pressure to this
level. Stay sutures placed proximal and distal to the intended
site of anastomosis secured the coronary artery. Proximal anas-
tomoses, where relevant, were constructed with a side-biting
clamp occluding a palpably normal portion of ascending aorta.
CPB. CPB was achieved with a pump flow rate of 2.4 L/m2
per minute at normothermia with temperature allowed to drift
to 34°C. Topical cooling was not used, and there was no
direct or indirect left ventricular venting. A membrane oxy-
genator (Cobe CML; Cobe Cardiovascular, Inc, Quedgeley,
Gloucester, United Kingdom) and a roller pump that pro-
duced nonpulsatile flow were used without an arterial line fil-
ter. Alpha-stat control of acid-base management was used,
and the mean arterial pressure was maintained between 50
and 60 mm Hg with pharmacologic manipulation if neces-
sary. Distal anastomoses were constructed during brief peri-
ods (approximately 10 minutes) of aortic clamping and
induced fibrillation. Proximal anastomoses were constructed
with a side-biting clamp.
Neuropsychologic and functional assessment. All
patients underwent neuropsychologic tests and a comprehen-
sive multidimensional measure of subjective health status
(SF36). One examiner (S.M.B.) administered a battery of 10
standardized neuropsychologic tests before the operation,
before discharge, and 3 months after the operation. The
examiner, who was responsible for recruitment of patients
into the anti-inflammatory study, was therefore not blinded to
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patients in the group without CPB. The tests are described in
detail elsewhere11 but included tests from a battery recom-
mended by a consensus conference on the assessment of neu-
robehavioral outcomes after cardiac operations.12 The tests
examine the following cognitive domains: premorbid intelli-
gence (National Adult Reading Test); verbal memory (Rey
Auditory Verbal Memory Test); attention (Digit span: for-
ward and backward, Trail-Making Tests A and B); psy-
chomotor speed (Nine Hole Pegboard Test); verbal perfor-
mance (verbal fluency); visual search (Bells test); speed of
information processing (Adult Memory Information Battery:
Test A), and general cognitive orientation (Short Orientation
Memory Concentration Test). To ascertain whether the neu-
ropsychologic deficits had an impact on daily functioning,
preoperative scores on the subjective health status measure
(SF36) were also compared with 3-month performance. 
Statistical analysis. Statistical analysis was undertaken
with the SPSS pc (version 6.1) computer program. Within
subject changes (between preoperative and discharge scores
and between preoperative and 3-month scores) were analyzed
separately with paired t tests. Between-group differences were
analyzed with independent t tests and 95% confidence intervals
(CIs; based on the calculated change scores). Patient charac-
teristics data (Table I) were analyzed with the c 2 test (for cate-
goric data) and the Mann-Whitney test (for continuous data).
Change scores for the trail-making test B were calculated after
the transformation of the raw scores to natural log values,
because the distribution of the raw change scores were not nor-
mal. To minimize the impact of nonrandomization, we per-
formed multiple regression analyses on baseline variables. 
Results
The 50 patients with CPB were drawn from an anti-
inflammatory study that showed no significant differ-
ence in neuropsychologic performance between the
active and placebo groups. Mann-Whitney tests on all
relevant data at all 3 time points showed no significant
difference in any neuropsychologic test at any time
point between the 50 patients drawn from the anti-
inflammatory study and the remainder of the patients in
that study. 
Patient demographics of the current study are sum-
marized in Table I. The groups were similar with
respect to age, sex, pre-existing hypertension, and ven-
tricular function. The number of grafts was significant-
ly higher in the CPB group with a mean ± standard
deviation (SD) of 2.7 ± 0.5 versus a mean of 1.5 ± 0.5
in the group without CPB. The operation times were
significantly different; the operation time for the group
without CPB was approximately 50 minutes shorter
than that for the group with CPB. The conditions of
patients in both groups were managed by the standard
unit policy of early extubation. Postoperative length of
stay was similar in the 2 groups, although patients who
would have been suitable for discharge at an earlier
date were requested to stay in the hospital for comple-
tion of neuropsychologic testing.
Tables II and III show the mean (SD) scores for each
test in both groups before operation and 5 days after
operation (Table II) and 3 months after operation
(Table III). The tables show the mean and 95% CI dif-
ference within each group and the mean and 95% CI
difference between the change scores in both groups at
5 days (Table II) and at 3 months (Table III). 
At discharge most neuropsychologic tests had deteri-
orated in both groups. In both groups the same 4 tests
had deteriorated significantly (speed of information
processing, right- and left-hand pegboard test, and
visual search) with a significant deterioration in one
other test in the CPB group (delayed recall). At 3
months all but one test result (visual search in the CPB
group) had returned to or exceeded baseline perfor-
mance. The same 2 tests had improved significantly in
both groups (speed of information processing and left-
hand pegboard test), and additionally the right-hand
pegboard test in the group without CPB. At no specific
time point was there a significant difference between
the absolute or change scores between the groups on
any of the tests.
The SF36 was completed by 46 patients with CPB
and all patients without CPB. Both groups showed sig-
nificant mean improvement in the physical functioning
component at 3 months. The CPB group increased
from 48 (25) to 70 (26) [mean improvement, 22; 95%
CI, 15%-30%: P < .0005] and the group without CPB
increased from 40 (29) to 63 (25) [mean improvement,
23; 95% CI, 11%-35%; P < .001]. Both groups also
Table I. Patient characteristics*
CPB Without CPB 
(n = 50) (n = 25) P value
Age (y) 58.9 ± 10.4 59.2 ± 10.2 .95
IQ estimate (NART) 108.8 ± 9.3 108.1 ± 8.5 .7
Sex (% male) 88 88 1.0
Elective (%) 70 56 .23
Hypertension (%) 38 40 .87
Diabetes (%) 16 20 .67
LV function (% normal) 74 84 .33






Operation time (min) 175 ± 46 126 ± 59 .0001
CPB duration (min) 68 ± 18 —
Length of hospital stay (d) 6.2 ± 1.8 6.3 ± 2.1 .98
IQ, Intelligence quotient; NART, National Adult Reading Test.
*Data given as mean and SD, unless otherwise indicated.
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showed significant improvement in the sociomental
component of the SF36. The CPB group increased from
59 (21) to 75 (19) [mean improvement, 16; 95% CI,
11%-21%; P < .0005] and the group without CPB
increased from 50 (25) to 73 (21) [mean improvement,
23; 95% CI, 16%-30%; P < .0005]. The mean differ-
ences between the change scores of each surgical group
at 3 months for each component of the SF36 were not
significant (physical: mean difference, –1; 95% CI,
–14%-13%; P = .91; sociomental: mean difference, –7;
95% CI, –15%-2%; P = .11). 
Because change scores can be biased by baseline
imbalance, particularly in nonrandomized studies, mul-
tiple regression equations were calculated with the dis-
charge and 3-month scores as the dependent variables
and the preoperative scores and the CPB group
(assigned dummy scores) as the independent variables.
This was done for each test at each time point, and on
no occasion did CPB become a significant independent
variable. In other words, by controlling for the preoper-
ative score, the presence or absence of CPB made no
difference to the dependent scores. 
Discussion
Before a discussion of the results of this study can
occur, it is important to consider the design and limita-
tions. We had already embarked on a trial of an anti-
inflammatory agent in a group of 150 patients under-
going conventional CABG with CPB when the
technical feasibility of CABG without CPB for certain
patients was described. 
The patients without CPB were defined only by the
absence of circumflex coronary artery and met all the
criteria to be entered into the anti-inflammatory trial.
Because less than 2% of our CABG population are
potentially suitable for revascularization without CPB,
it was not practical, given the time frame, to randomize
these patients between CPB and without CPB. The
patients without CPB were, in effect, selectively with-
drawn from the anti-inflammatory trial but followed
Table II. Mean (± SD) neuropsychologic test performance, comparing preoperative and discharge scores (5 days)
for patients with and without CPB
Difference between 
Difference within the mean change score P value 
Preoperative Discharge groups for both groups CPB vs 
Test Group N mean mean (95% CI) P value (95% CI) without CPB
Immediate recall CPB 49 40.6 (7.9) 40.1 (8.2) –0.6 (–2.2/+1.1) .51 –2.0 (–1.3/+5.3) .22
Without CPB 23 42.4 (9.7) 39.9 (10.6) –2.6 (–5.9/+0.7) .12
Delayed recall CPB 49 15.0 (5.8) 12.6 (5.5) –2.4 (–3.6/–1.1) .0001 –1.2 (–3.1/+2.8) .89
Without CPB 22 16.2 (5.9) 14.0 (5.9) –2.2 (–4.9/+0.5) .11
Speed of information CPB 49 66.1 (16.1) 58.7 (17.4) –7.1 (–9.9/–5.0) .0001 –3.4 (–7.6/+0.9) .12
processing Without CPB 23 61.8 (16.9) 57.7 (18.2) –4.1 (–7.7/–0.5) .03
Trail making, test A* CPB 50 36.6 (13.4) 38.5 (13.8) –1.9 (–4.2/+0.3) .09 1.0 (–3.3/+5.3) .65
Without CPB 23 33.7 (9.7) 36.6 (14.4) –3.0 (–7.3/+1.4) .17
Trail making, test B* CPB 47 91.2 (33.7) 122.3 (73.6) –31.1 (NA) — 7.1 (–22.3/+36.4) .61
Without CPB 23 94.3 (31.4) 132.4 (90.1) –38.2 (NA) —
Pegboard, right hand* CPB 49 18.9 (2.2) 20.8 (2.7) –1.9 (–2.4/–1.5) .0001 –0.7 (–1.9/+0.7) .32
Without CPB 23 19.5 (2.9) 20.7 (3.1) –1.3 (–2.5/0) .05
Pegboard, left hand* CPB 49 20.8 (3.5) 22.4 (4.1) –1.6 (–2.4/–0.8) .0001 –0.6 (–1.9/+0.7) .38
Without CPB 22 21.1 (3.2) 22.2 (3.9) –1.0 (–1.9/–0.2) .02
Verbal fluency CPB 49 38.2 (12.8) 37.2 (12.1) –1.0 (–3.1/+1.0) .32 –1.06 (–4.9/+2.8) .59
Without CPB 22 39.0 (12.5) 39.1 (12.0) +0.1 (–3.8/+3.9) .98
Digit span (forward) CPB 49 6.4 (1.2) 6.3 (1.3) –0.1 (–0.5/+0.2) .4 –0.4 (–0.9/+0.2) .16
Without CPB 23 6.0 (1.3) 6.3 (1.4) +0.3 (–0.2/+0.2) .21
Digit span CPB 49 4.9 (1.3) 4.7 (1.5) –0.2 (–0.5/+0.1) .12 –0.4 (–0.9/+0.1) .13
(backward) Without CPB 23 4.6 (1.2) 4.7 (1.3) +0.1 (–0.2/+0.7) .48
Visual search CPB 49 2.2 (2.2) 1.6 (1.6) +0.6 (–0.1/+1.3) .09 –0.2 (–1.4/+1.0) .78
Without CPB 23 1.9 (2.1) 1.2 (1.7) +0.8 (–0.1/+1.7) .09
SOMCT CPB 50 25.2 (2.4) 24.9 (3.1) –0.3 (–1.1/+0.5) .42 –0.5 (–20/+1.0) .51
Without CPB 23 25.1 (2.7) 25.3 (3.2) +0.2 (–1.3/1.7) .81
SOMCT, Short Orientation Memory Concentration Test.
Slight discrepancies in results are due to rounding up/down of decimal figures. On most tests, a higher score represents better performance. Tests marked with an
asterisk (*) used time measurement; consequently, higher scores represent poorer performance. Raw scores are used for Trail Making Tests A and B. In the case of
Trail Making Test B, all preoperative scores of more than 200 seconds were excluded from analysis, and all noncompleted tests were assigned a time of 331 seconds
(equal to the largest completed time). Given the distribution of change scores for Trail Making Test B, the Mann-Whitney U test was used.
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the same assessment protocol, because the postulated
benefits of avoiding CPB have not yet been established. 
The 50 patients with CPB were drawn from an anti-
inflammatory drug trial that showed no difference in
postoperative cognitive function between the active and
placebo groups. These 50 patients showed no signifi-
cant difference in any neuropsychologic test at any
time point from the remainder of the patients in that
study. Although we did not randomize the current
study, the groups were matched for age, sex, pre-exist-
ing hypertension, and ventricular function. Advanced
age (>70 years) and severe impairment of ventricular
function (ejection fraction < 30%) may influence,
albeit weakly, postoperative cognitive function.2,9 The
mean age of patients in our study was less than 60
years, and patients with significantly impaired ventric-
ular function were excluded. Furthermore, multiple
regression analysis showed that minor differences in
preoperative variables did not influence our results. 
A potential weakness of our study was that the neu-
ropsychologic tests were performed by one observer
who was not blinded to the groups with and without
CPB. In addition to the fact that many of the neuropsy-
chologic tests are objective and quantifiable assess-
ments of cognitive performance and not easily influ-
enced by the examiner, our postulated a priori bias was
that the group without CPB would perform better than
the group with CPB by avoiding CPB. That the patients
without CPB also had less severe coronary artery dis-
ease (suggesting the possibility of less widespread arte-
rial disease) and shorter operating times was expected
to support this postulate. 
On the multidimensional health questionnaire
(SF36), both groups showed a similar significant
improvement at 3 months. The more surprising obser-
vation in our study was the similarity of cognitive
impairment at discharge and the lack of difference in
cognitive performance at 3 months. Considering that
Table III. Mean (± SD) neuropsychologic test performance comparing preoperative and 3-month scores for
patients with and without CPB
Difference between 
Difference within the mean change score P value 
Preoperative Discharge groups for both groups CPB vs 
Test Group N mean mean (95% CI) P value (95% CI) without CPB
Immediate recall CPB 50 40.3 (8.2) 40.8 (9.1) +0.5 (–1.2/+2.3) .53 0.2 (–2.7/+3.1) .9
Without CPB 25 42.6 (9.6) 42.9 (9.1) +0.4(–2.0/+2.7) .76
Delayed recall CPB 50 14.8 (6.0) 13.7 (6.2) –1.0 (–2.2/+0.2) .09 0.0 (–2.2/+2.1) .99
Without CPB 25 16.4 (5.7) 15.4 (6.4) –1.0 (–2.9/+0.9) .30
Speed of information CPB 50 65.7 (16.2) 68.5 (18.3) +2.8 (+0.4/+5.1) .02 –2.7 (–6.4/+1.1) .16
processing Without CPB 25 63.1 (16.9) 68.6 (18.7) +5.4 (+2.9/+7.9) .001
Trail Making Test A* CPB 50 36.6 (13.4) 34.1 (9.9) +2.5 (–0.6/+5.5) .11 0.6 (–4.1/+5.3) .79
Without CPB 25 33.0 (9.5) 31.2 (10.9) +1.8 (–0.9/+4.7) .19
Trail Making Test B* CPB 47 91.2 (33.7) 88.2 (45.1) +3.0 (NA) — –0.6 (–17.1/+15.9) .98
Without CPB 25 92.2 (31.3) 88.6 (33.8) +3.6 (NA) —
Pegboard, right hand* CPB 50 18.8 (2.2) 18.4 (2.1) +0.4 (–0.1/+0.9) .08 –0.5 (–1.5/+0.5) .32
Without CPB 25 19.3 (2.9) 18.4 (2.5) +0.9 (0.0/+1.8) .04
Pegboard, left hand* CPB 50 20.8 (3.4) 19.8 (3.1) +1.0 (+0.3/+1.7) .004 –0.30 (–1.4/+0.8) .62
Without CPB 24 21.0 (3.1) 19.7 (2.9) +1.3 (+0.4/+2.1) .004
Verbal fluency CPB 50 37.9 (12.8) 38.6 (12.3) +0.7 (–1.7/+3.0) .57 –0.1 (–3.8/+3.7) .97
Without CPB 25 39.1 (12.3) 39.8 (10.9) +0.7 (–1.9/+3.3) .57
Digit span (forward) CPB 50 6.4 (1.3) 6.6 (1.3) +0.2 (–0.1/+0.2) .14 –0.3 (–0.8/+0.3) .33
Without CPB 25 6.0 (1.3) 6.5 (1.2) +0.5 (0.0/+0.9) .06
Digit span CPB 50 4.9 (1.3) 4.9 (1.5) +0.1 (–0.2/+0.4) .58 –0.1 (–0.6/+0.4) .63
(backward) Without CPB 25 4.6 (1.1) 4.8 (1.3) +0.2 (–0.2/+0.6) .33
Visual search CPB 50 2.2 (2.2) 1.3 (1.3) +0.9 (+0.4/+1.5) .002 0.7 (0.3/+1.7) .19
Without CPB 25 1.9 (2.0) 1.7 (1.6) +0.2 (–0.7/+1.2) .60
SOMCT CPB 50 25.2 (2.4) 25.5 (3.3) +0.3 (–0.6/+1.2) .52 –0.2 (–1.6/+1.2) .78
Without CPB 25 24.9 (2.7) 24.4 (2.4) +05 (–0.6/+1.6) .37
SOMCT, Short Orientation Memory Concentration Test. Slight discrepancies in results are due to rounding up/down of decimal figures. On most tests, a higher score
represents better performance. Tests marked with an asterisk (*) used time measurement; consequently, higher scores represent poorer performance. Raw scores are
used for Trail Making Tests A and B. In the case of Trail B, all preoperative scores of more than 200 seconds were excluded from analysis, and all noncompleted
tests were assigned a time of 331 seconds (equal to the largest completed time). Given the distribution of change scores for Trail Making Test B, the Mann-Whitney
U test was used.
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the group without CPB also had less severe coronary
artery disease and shorter operating times makes our
observations even more striking. At discharge most
tests were impaired in comparison with preoperative
baseline in both groups: at 3 months, all but a single
test in the CPB group had returned to or exceeded base-
line performance. Although the absence of improve-
ment in any test on repeated examination might itself
represent some degree of impairment, this should apply
to both groups and therefore would not invalidate the
comparison between the groups.
Cognitive dysfunction has been reported to persist for
several months or even years after CABG. The return to
baseline scores for most tests in our CPB group at 3
months is, however, in keeping with data from recent
studies that report significant improvements in cogni-
tive function late after cardiac operations17,18 and the
clinical impression that cognitive impairment is now
uncommon late after cardiac operations. This reduction
in late cognitive impairment is probably due to refine-
ments in extracorporeal circulation including the use of
arterial line filters13 and membrane oxygenators14,15
and improved control of acid-base balance.16
Our results are also consistent with earlier studies
that suggested that CBP was not the sole cause of cere-
bral dysfunction after cardiac operations.3-9 Our find-
ings confirm and extend the recent study of Malheiros
and colleagues,19 who reported no difference in neuro-
logic or neuropsychologic outcome on postoperative
day 7 in patients undergoing CABG with or without
CPB.
Collectively, these studies question the established
dogma that CPB is responsible for cognitive impair-
ment after cardiac operations, at least in patients under-
going closed operations and with at least moderate ven-
tricular function. If, however, CPB is not specifically
responsible for cognitive impairment at early and late
follow-up, what alternative intraoperative components
common to both operations could be involved? Several
candidates present themselves that include hypoten-
sion, general surgical injury, and anesthesia.
Although severe intraoperative hypotension may
cause cognitive dysfunction, most prospective studies
have failed to confirm this when mean arterial pressure
is maintained above 50 mm Hg,20-24 a level at which
cerebral autoregulation normally occurs. In our study
the mean blood pressure was maintained at 50 to 60
mm Hg in both groups.
The contribution of the general effects of surgical
injury warrants consideration, given previous findings
that patients undergoing major noncardiac operation
also showed cognitive dysfunction.3-9 These studies
cannot, however, distinguish the effects of surgical
injury from those of concomitant anesthesia. To resolve
this issue would require submitting age-matched
patients to the same anesthetic regimen but without
operation, not an ethical proposition. 
Could the pattern of neuropsychologic impairment
after CABG, with or without CPB, and other forms of
operation be explained in terms of the effects of the anes-
thetic regimen? Although it is generally recognized that
anesthesia can produce short-term cognitive dysfunc-
tion,25,26 the long-term effects remain open to ques-
tion.27,28 Furthermore, when evaluating the effects of
anesthesia, most studies typically consider only the
effects of a single agent. Few, if any, consider the poten-
tial for the cumulative and/or interactive effects of differ-
ent agents commonly used.29 As emphasized by Klafta
and colleagues,27 however, the typical anesthetic regimen
for cardiac operations produces “deeper anaesthesia than
is normally required for non-cardiac operation.”
In the largest trial to date that investigated the effects
of general and epidural anesthesia in orthopedic
patients, 5% of all patients showed clinically signifi-
cant deterioration on a large battery of neuropsycho-
logic tests at 6 months.28 Furthermore, 27% of all
patients showed a clinically important deterioration in
verbal memory at 6 months. The authors speculate that
this cognitive dysfunction might result from anesthetic-
dependent cerebral ischemia or disturbances of cerebral
autoregulation.28 Taken together, these studies suggest it
is pertinent to re-examine the role of polypharmacy of
particular anesthetic regimens when considering post-
operative cognitive dysfunction.
Although our results confirm previous reports of an
early deterioration in neuropsychologic function after
cardiac operations, they clearly imply that this is not
exclusive to the use of CPB. Avoidance of cerebral dys-
function has been used as a major reason for promoting
minimally invasive operations over conventional CABG
with CPB despite inferior long-term results. Our results,
however, suggest that the particular anesthetic regimen
in association with nonspecific effects of the general
operation may be responsible for producing the com-
mon pattern of cognitive dysfunction after cardiac oper-
ations. This merits further investigation. 
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Commentary
In this provocative study, Taggart and colleagues
have apparently been unable to demonstrate any mean-
ingful differences in postoperative cognitive outcomes
in patients undergoing coronary revascularization with
or without the use of cardiopulmonary bypass (CPB).
Although there may be some significant methodologic
points at issue relating to the detection of cognitive
dysfunction and revolving around the use of group
mean analysis, as used here, versus incidence analysis,
as has been recommended elsewhere,1 the clinical mes-
sage appears to be that there are no meaningful differ-
ences in cognitive outcomes irrespective of whether or
not CPB is used. Before this result is uncritically
accepted and generalized, however, careful considera-
tion must be given to the specific conditions of this
study.
In the first instance, this study was not randomized.
The 50 patients comprising the CPB group were in fact
drawn as a subset from 150 patients undergoing a sep-
arate, randomized controlled trial of an anti-inflamma-
tory agent. Since this group was matched post hoc for
age and sex with the 25 patients in whom CPB was not
used (no CPB), and necessarily included only those
patients with complete data sets, CPB patients with sig-
nificant complications (eg, mortality, stroke, important
hemodynamic complications) or those lost to follow-up
would not have been represented in the CPB compari-
son group. This fact alone raises the possibility of sig-
nificant inadvertent bias in favor of the CPB group.
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Irrespective of this confound, however, the fact
remains that for these selected groups these data, as
analyzed, do not appear to show any meaningful differ-
ences in outcome ascribable to use of CPB. What else
is different about these groups? Certainly the average
age of the 2 study groups is considerably younger than
that for those undergoing surgical coronary revascular-
ization in North America. On the basis of the latest fig-
ures available from The Society of Thoracic Surgeons
Adult Cardiac National Database, the average age of
patients undergoing coronary artery bypass grafting
(CABG) in North America in 1996 was 64.7 ± 10.6
years.2 This is in contrast to the mean age of 58.9 ± 10
years in the current study. Is this germane? The risks of
neurologic and cognitive injury after CPB are largely
determined by age. In a prospective study of 2108
patients undergoing CABG, 32% of patients were aged
70 years or older, and older age was shown to be a sig-
nificant independent risk factor for both stroke (type I)
and deterioration of intellectual function (type II) out-
comes.3 Others have also shown a specific association
between age and postoperative cognitive dysfunction in
patients undergoing conventional CABG.4 Given that
the proportion of CABG patients older than 70 years
exceeds 30% in most clinical practices in North
America, before determining operative strategy on the
basis of the results of the current study, we must be
fully aware that although these results may apply, they
may well apply only to those patients younger than 60
years.
John M. Murkin, MD, FRCPC
London, Ontario, Canada
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